Personal profile
Research interests
Our lab is dedicated to understanding the complex interplay between immune responses and the tumor microenvironment, focusing on how these factors both shape and are shaped by tumor progression and the response to anti-cancer therapies. We strive to identify key vulnerabilities within this dynamic system and harness them to improve patient outcomes, particularly by enhancing the efficacy of conventional treatments and immunotherapies.
Mentoring
The DeNardo Lab is dedicated to training the next generation of scientists and cancer researchers. As such, our group welcomes all individuals, regardless of physical ability, gender, sexual orientation, age, race/ethnicity, religion, or cultural background.
We are a team of scientists with diverse backgrounds and experiences, who have created a nurturing and inclusive environment that fosters a sense of belonging. United by a common goal—to fight cancer through research—we measure our success not only by the discoveries we make but also by the community we build to achieve them. Additionally, we take pride in the career and personal growth of each individual involved in our research as they progress through their training journey within our team.
Available to Mentor:
- PhD Students
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Brain-engrafted monocyte-derived macrophages from blood and skull-bone marrow exhibit distinct properties
Du, S., Ou, F., Drieu, A., Xu, E. Z., Cheng, Y., Storck, S. E., Mamuladze, T., Cao, J., Abduljawad, N., Bhattarai, B., Rustenhoven, J., Mortimer, N., Brioschi, S., Nguyen, K., Rodrigues, P. F., Smirnov, I., Gibson, D., Michael White, J., Beatty, W. & DeNardo, D. & 8 others, , 2026, (Accepted/In press) In: Neuron.Research output: Contribution to journal › Article › peer-review
Open Access -
Chemotherapy-induced adipo-lineage cell senescence drives bone loss
Raut, G. K., Malachowski, T., Melam, A., Ramalho-Oliveira, R., Holt, T., Luo, X., Yao, Z., Faget, D. V., Ren, Q., DeNardo, D. G. & Stewart, S. A., Dec 2026, In: Nature communications. 17, 1, 1042.Research output: Contribution to journal › Article › peer-review
Open Access -
Therapeutic reprogramming of tumour-associated macrophages in pancreatic cancer using a cytotoxic CCR2-targeted nanotheranostic
Somani, V. K., Zhang, X., Chen, T. H. P., Bulle, A., Bansod, S., Li, L., Geng, Y., Kang, L. I., Heo, G. S., Luehmann, H., Zhang, Y., Saeed, M. A., Lavine, K. J., DeNardo, D. G., Pachynski, R. K., Liu, Y. & Lim, K. H., Dec 2026, In: Molecular Cancer. 25, 1, 65.Research output: Contribution to journal › Article › peer-review
Open Access -
Combined Flt3L and CD40 agonism restores dendritic cell–driven T cell immunity in pancreatic cancer
Hogg, G. D., Weinstein, A. G., Kingston, N. L., Liu, X., Dres, O. M., Kang, L. I., Lander, V. E., Kao, Y. L., Ahmad, F., Knolhoff, B. L., Shenoy, V. V., Sells, B., Jayasinghe, R. G., Houston, A., Liu, T., Herndon, J. M., Murphy, K. M., Ding, L., Fields, R. C. & Panni, R. Z. & 2 others, , Aug 2025, In: Science immunology. 10, 110, eadp3978.Research output: Contribution to journal › Article › peer-review
Open Access10 Link opens in a new tab Scopus citations -
HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma
Yamamoto, N., Dobersch, S., Loveless, I., Samraj, A. N., Jang, G. H., Haraguchi, M., Kang, L. I., Ruzinova, M. B., Vij, K. R., Mudd, J. L., Walsh, T., Safyan, R. A., Chiorean, E. G., Hingorani, S. R., Bolton, N. M., Li, L., Fields, R. C., DeNardo, D. G., Notta, F. & Crawford, H. C. & 2 others, , Feb 15 2025, In: Clinical Cancer Research. 31, 4, p. 733-745 13 p.Research output: Contribution to journal › Article › peer-review
Open Access10 Link opens in a new tab Scopus citations